Insulin-like growth factor 1 (IGF-1), also called somatomedin C, is a member of the insulin family of polypeptide growth factors. It is also one of three protein hormones that share structural similarity to insulin. IGF-1 has a molecular weight of 17,066 daltons, consists of 70 amino acids in a single chain with three intramolecular disulfide bridges. It is produced primarily by the liver as an endocrine hormone as well as in target tissues in a paracrine/autocrine fashion. Its primary action is mediated by binding to its specific receptor, the Insulin-like growth factor 1 receptor, initiates intrIGF-1llular signaling. It is a primary mediator of the effects of growth hormone (GH). It also plays an important role in childhood growth and continues to have anabolic effects in adults.
Product Code:
BEK1082
Product:
IGF-1, Human, ELISA Kit
Application:
For quantitative detection of IGF-1 in mouse serum, plasma, urine, cell culture supernatant or tissue samples.
Background:
Insulin-like growth factor 1 (IGF-1), also called somatomedin C, is a member of the insulin family of polypeptide growth factors. It is also one of three protein hormones that share structural similarity to insulin. IGF-1 has a molecular weight of 17,066 daltons, consists of 70 amino acids in a single chain with three intramolecular disulfide bridges. It is produced primarily by the liver as an endocrine hormone as well as in target tissues in a paracrine/autocrine fashion. Its primary action is mediated by binding to its specific receptor, the Insulin-like growth factor 1 receptor, initiates intrIGF-1llular signaling. It is a primary mediator of the effects of growth hormone (GH). It also plays an important role in childhood growth and continues to have anabolic effects in adults.
Detection Range:
62.5 pg/ml-4000 pg/ml
Sensitivity:
< 10 pg/ml
Reactivity:
Human
OMIM:
147440
SwissProt:
P05019
Gene ID:
3479
Principle of the Assay:
This kit was based on standard sandwich enzyme-linked immune-sorbent assay technology. The purified anti-IGF-1 antibody was pre-coated onto 96-well plates. And the HRP conjugated anti-IGF-1 antibody was used as detection antibodies. The standards, test samples and HRP conjugated detection antibody were added to the wells subsequently, mixed and incubated, then, unbound conjugates were washed away with wash buffer. TMB substrates (A & B) were used to visualize HRP enzymatic reaction. TMB was catalyzed by HRP to produce a blue color product that changed into yellow after adding acidic stop solution. The density of yellow is proportional to the IGF-1 amount of sample captured in plate. Read the O.D. absorbance at 450nm in a microplate reader, and then the concentration of IGF-1 can be calculated.
Detection Range
62.5 pg/ml-4000 pg/ml
Sensitivity
< 10 pg/ml
Uniprot
P05019
Background
Insulin-like growth factor 1 (IGF-1), also called somatomedin C, is a member of the insulin family of polypeptide growth factors. It is also one of three protein hormones that share structural similarity to insulin. IGF-1 has a molecular weight of 17,066 daltons, consists of 70 amino acids in a single chain with three intramolecular disulfide bridges. It is produced primarily by the liver as an endocrine hormone as well as in target tissues in a paracrine/autocrine fashion. Its primary action is mediated by binding to its specific receptor, the Insulin-like growth factor 1 receptor, initiates intrIGF-1llular signaling. It is a primary mediator of the effects of growth hormone (GH). It also plays an important role in childhood growth and continues to have anabolic effects in adults.
Supplier
BioSpes
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.